找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Atlas of Osteoporosis; Eric S. Orwoll (Professor of Medicine, Program Dir Book 2003Latest edition Springer Science+Business Media New York

[复制链接]
楼主: HAG
发表于 2025-3-26 23:55:51 | 显示全部楼层
发表于 2025-3-27 04:08:50 | 显示全部楼层
发表于 2025-3-27 06:46:22 | 显示全部楼层
发表于 2025-3-27 10:47:27 | 显示全部楼层
Book 2003Latest editiondvancement. Some chapters included in the First Edition have been more extensively revised to reflect major developments. Several chapters have been added to highlight the emergence of new fields (genetics) or the expansion of others (bone densitometry and the laboratory evaluation of bone disorders).
发表于 2025-3-27 17:25:30 | 显示全部楼层
发表于 2025-3-27 17:55:08 | 显示全部楼层
Operator Theory: Advances and Applicationstime, virtually all drugs, except one, that are approved by the US Food and Drug Administration (FDA) for the treatment of established osteoporosis act to inhibit bone resorption. These include calcitonin, estrogen, raloxifene (Evista; Lilly, Indianapolis, IN), risedronate, and alendronate.
发表于 2025-3-28 00:53:39 | 显示全部楼层
发表于 2025-3-28 06:00:13 | 显示全部楼层
Bone Anabolic Agents,time, virtually all drugs, except one, that are approved by the US Food and Drug Administration (FDA) for the treatment of established osteoporosis act to inhibit bone resorption. These include calcitonin, estrogen, raloxifene (Evista; Lilly, Indianapolis, IN), risedronate, and alendronate.
发表于 2025-3-28 07:24:05 | 显示全部楼层
The Nature of Osteoporosis,s led to many important advances in the understanding of and therapeutics for this disease. Whereas the topic of osteoporosis formerly occupied just a few paragraphs in standard texts, it is now the primary focus of several journals and textbooks. This volume provides current information regarding s
发表于 2025-3-28 11:01:40 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-13 18:57
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表